- Home
- BYSI vs APYX Comparison
BYSI vs APYX Comparison
Compare BYSI & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYSI
- APYX
- Stock Information
- Founded
- BYSI 2010
- APYX 1982
- Country
- BYSI United States
- APYX United States
- Employees
- BYSI N/A
- APYX N/A
- Industry
- BYSI Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- BYSI Health Care
- APYX Health Care
- Exchange
- BYSI Nasdaq
- APYX Nasdaq
- Market Cap
- BYSI 72.1M
- APYX 61.7M
- IPO Year
- BYSI 2017
- APYX 1987
- Fundamental
- Price
- BYSI $1.79
- APYX $1.51
- Analyst Decision
- BYSI
- APYX Hold
- Analyst Count
- BYSI 0
- APYX 2
- Target Price
- BYSI N/A
- APYX N/A
- AVG Volume (30 Days)
- BYSI 10.8K
- APYX 16.8K
- Earning Date
- BYSI 01-01-0001
- APYX 03-20-2025
- Dividend Yield
- BYSI N/A
- APYX N/A
- EPS Growth
- BYSI N/A
- APYX N/A
- EPS
- BYSI N/A
- APYX N/A
- Revenue
- BYSI $1,876,000.00
- APYX $48,542,000.00
- Revenue This Year
- BYSI N/A
- APYX N/A
- Revenue Next Year
- BYSI N/A
- APYX $2.50
- P/E Ratio
- BYSI N/A
- APYX N/A
- Revenue Growth
- BYSI 21.03
- APYX N/A
- 52 Week Low
- BYSI $1.05
- APYX $0.97
- 52 Week High
- BYSI $4.00
- APYX $2.30
- Technical
- Relative Strength Index (RSI)
- BYSI 56.87
- APYX 53.42
- Support Level
- BYSI $1.61
- APYX $1.42
- Resistance Level
- BYSI $1.88
- APYX $1.56
- Average True Range (ATR)
- BYSI 0.10
- APYX 0.08
- MACD
- BYSI 0.00
- APYX 0.01
- Stochastic Oscillator
- BYSI 66.67
- APYX 81.41
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.